PPARA and metabolic dysfunction-associated steatotic liver disease: Moreover, miR-30a-3p was found to be significantly elevated in MASLD patients, and it regulated the degree of steatosis by directly targeting PPAR-α, further linking miRNAs to lipid metabolism in the liver [66].